India Pesticides Ltd reports Q2 FY25 consolidated PAT at Rs. 26 Cr, up 32.9% YoY with PAT margin of 11.1%

• Delivered strong performance on both YoY and QoQ basis

• Total Revenue of Rs. 234 Cr, up by 13.6% YoY and 4.5% QoQ

• EBITDA of Rs. 39 Cr, up by 25.2% YoY, with EBITDA margin of 16.6%

• Net Profit of Rs. 26 Cr, up 32.9% YoY with PAT margin of 11.1%

India Pesticides Limited (BSE: 543311; NSE: IPL), one of the fast growing agro-chemical companies for technical manufacturing (″IPL″ or the ″Company″), announces its results for quarter and half year ended September 30^th, 2024.

Q2 & H1 FY25 Financial Performance:

Q2 FY25 Key Performance Highlights:

• Total Income was Rs. 234 Cr, an increase of 13.6% and 4.5% on YoY and QoQ respectively

• EBITDA of Rs. 39 Cr, an increase of 25.2% on YoY with EBITDA margin of 16.6%

• Net Profit of Rs. 26 Cr, an increase of 32.9% on YoY with PAT margin of 11.1%

H1 FY25 Key Performance Highlights:

• Total Income was Rs. 458 Cr, an increase of 11.5% on YoY basis

• EBITDA of Rs. 71 Cr, an increase of 23.9% on YoY with EBITDA margin of 15.5%

• Net Profit of Rs. 45 Cr, an increase of 29.6% on YoY with PAT margin of 9.9%

• Cash Flow from Operations stood at Rs.17 Cr

Commenting on the performance, Mr. Anand S. Agarwal, Director, Founder & Promoter said:

″We continued our growth momentum in the second quarter of FY25 and achieved a Revenue growth of 13.6%, driven by increased volumes. This growth was further supported by favourable agricultural conditions, including above-average monsoon rainfall and higher crop sowing, which positively impacted demand.

Despite global industry challenges, including subdued demand and pricing pressures, we delivered a robust performance, marked by significant margin expansion across our key metrics. This improvement in margins highlights the effectiveness of our focus on operational efficiencies, high-quality niche products, and disciplined cost management, which together enabled us to enhance profitability even in a challenging market environment.

Our expansion initiatives are progressing as planned, strengthening our core capabilities and advancing infrastructure to support the production of specialty products. Looking ahead, we are focused on growth through expanding our customer base and enhancing our capabilities. Committed to continuous R&D and innovation, we are building a robust pipeline of products to meet evolving customer needs and maintain our competitive edge.

Driven by our commitment to customer satisfaction, operational excellence, and social responsibility, we are prepared to navigate uncertainties and emerge stronger, backed by the unwavering support of our stakeholders.″

Key Strategic Developments/Updates:

• Successfully commissioned our intermediate plant, a significant step towards the backward integration of one of our key fungicides, which was previously imported

• ~110 Cr of Capex has been planned for FY25 for both IPL & SSL and is progressing as planned